What Do You Know About Health Quality Measures for Opioid Use Disorder?

Tools that assess care can help fill gaps in treatment

Navigate to:

What Do You Know About Health Quality Measures for Opioid Use Disorder?
Nurse prepares surgical paperwork
Getty Images

To improve treatment for opioid use disorder (OUD), it is essential to assess care delivery using quality measures—tools that help measure or quantify health care processes, outcomes, and more. Yet although many states track overdose deaths, most are not reporting data on the effectiveness of treatment or the use of medications for OUD—the most effective form of treatment. In recognition of National Healthcare Quality Week, Oct. 16-22, see how much you know about this issue.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Doctor speaking with patient
Doctor speaking with patient
Issue Brief

States Should Measure Opioid Use Disorder Care

Quick View
Issue Brief

The most effective treatments for opioid use disorder (OUD) are medications: methadone, buprenorphine, and naltrexone. However, there are substantial gaps between the number of people who need these medications and those who receive them, and the United States continues to experience a devastating number of lives lost to the opioid epidemic.

A recovering drug user takes a dose of methadone
Article

How States Can Measure Effectiveness of OUD Care

Quick View
Article

Over the past year, drug overdose deaths in the United States have hit record levels, with the Centers for Disease Control and Prevention reporting more than 100,000 fatalities between April 2021 and April 2022. An equally troubling statistic, though, is that most people with opioid use disorder (OUD) who would benefit from lifesaving therapies—that is, FDA-approved medications, including methadone, buprenorphine, and naltrexone—do not receive them.